Keywords: shire, beats, expectations, third, quarter, adhd, product
Shire beats expectations in third quarter as ADHD product sales soar
Article | 17 November 2003
Shire Pharmaceuticals, the UK's third-largest drugmaker by sales, hasreported a better-than-expected set of financial results for the third quarter of 2003, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
